Shiseido's 90% Profit Jump Hides a Problem: Sales Still Aren't Growing

Shiseido's profit jump looks real, but sales are still the sticking point

After reporting on Aug. 5, the key question is straightforward: can a beauty company with core operating profit surged 90% to ¥44.4bn truly be called healthy while net sales were flat on a like-for-like basis? That tension defines the quarter.

Bulls see evidence that the turnaround is working: better product mix, tighter costs, and more profit emerging before revenue picks up meaningfully. Bears argue that profit growth without sales growth often reflects cost control more than stronger demand. For now, both readings have a case.

What improved

Shiseido is clearly getting better at converting sales into earnings. That matters, especially for a company in the early stages of a turnaround.

But the improvement is uneven. Japan and China, including travel retail, remained flat, and those are still core markets for Shiseido. A business can cut its way to better margins for a while, but a lasting rerating usually needs broader consumer demand.

Why the next update matters

The next major check is Nov. 10. Until then, investors can view this quarter as early turnaround progress. After that, the market will likely want harder proof: sales that actually grow, not just profits that look better.

Brand performance shows promise, but not a full portfolio recovery

The quarter does not tell a clean story. Some brands and categories are gaining traction, but not enough to prove the whole portfolio is selling better everywhere.

Signs of real demand

• Asia Pacific grew 2% in H1
• NARS Cosmetics and Cle de Peau de Beauté grew 3% and 2% respectively in the first half
• the latter's growth accelerating to 6% in the second quarter

That mix is encouraging. It suggests some brands are finding buyers again rather than relying only on past goodwill.

Where the pressure remains

The broader picture is still mixed:

• Shiseido declined 3% in the first half
• Japan and China, including travel retail, remained flat
• The Americas and EMEA declined 1%
• Drunk Elephant sales declined 12% in H1, and 9% in Q2
• The launch of NARS' Natural Matte Longwear Foundation "missed expectations", largely in the US

That tells you the brand engine is only partially warmed up. There are real proof points, but not yet broad-based strength.

The dividend helps sentiment, but it is not proof of stronger sales

A Q2 cash dividend of ¥30 per share, with payments set to start on Sept. 3, is a supportive signal. But in beauty, investors usually pay more attention to customer traction than to dividend calendars.

The more important catalyst is Nov. 10. The core debate will remain the same: core operating profit surged 90%, yet net sales of ¥499bn were flat on a like-for-like basis. Bulls can argue the turnaround is taking hold. Bears can argue management is still squeezing better numbers out of flat sales.

What to watch before the next move

For now, this looks like a turnaround to verify, not to chase blindly. The next few quarters should make clear whether Shiseido is building broader demand or simply managing through a mixed patch.